CHICAGO, April 28, 2020 /PRNewswire/ -- Kaufman Hall, a leading provider of enterprise performance management (EPM) software, data, and management consulting services, announced today the availability of several new tools to help hospitals and health systems better understand COVID-19-related clinical and operational data. These broader insights will assist healthcare organizations as they monitor and improve care, adjust budgets and analyze the impact that COVID-19 activities have across a variety of measures, including mortality rate, length of stay, cost of care, ICU utilization, budget forecasts, revenue, expenses and more.
These new tools will help healthcare organizations understand, prepare for and quickly respond to COVID-19:
A rapid deployment model for Kaufman Hall's Axiom Rolling Forecasting and Comparative Analytics solutions, which provides healthcare organizations with the industry's most robust and timely market insights and drives effective planning and resource allocation by simulating alternative views of an uncertain future. This powerful combination of scenario modeling and machine learning techniques helps healthcare leaders wisely adjust their 2020 budgets — which have been significantly impacted by COVID-19 — and provides budget and operations insights to guide finance and strategy teams as they create action plans to improve financial performance.
Ad Statistics
Times Displayed: 6679
Times Visited: 20 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
New Axiom Intelligence dashboards in the Decision Support Solution, which are designed to demonstrate the impact of key COVID-19 populations using easy data visualizations. The dashboards help healthcare organizations monitor ongoing and dynamic changes to volumes, understand new populations across a number of key demographic, geographic and operational dimensions, and quickly investigate the utilization activity and cost of critical resources like beds, equipment, drugs and supplies. These insights are key to both resourcing in the short term and planning for the future.
New scorecards in Axiom Clinical Analytics that deliver rapid access to key clinical and operational data on COVID-19 diagnoses, such as acute bronchitis due to COVID-19, acute respiratory distress syndrome due to COVID-19, coronavirus diagnosis emergency department, and more. Such insights are crucial for monitoring and assessing quality during the outbreak so that clinical leaders can rapidly adjust strategies to improve outcomes in the months to come.
